Reprieve Cardiovascular is Diagnostic Equipment in United States that focus on medical device business. Founded in 2018. They cover business area such as developer, an acute decompensate heart failure, (ADHF) treatment medical device, patient, life, limit, diuretic therapy, precise and predictable management, dangerous fluid imbalance, control, medical practitioner.
2018
( 6 years old in 2024 )
Medical Device
-
459 Fortune Boulevard
Milford, MA 01757
United States
Private
developeran acute decompensate heart failure(ADHF) treatment medical devicepatientlifelimitdiuretic therapyprecise and predictable managementdangerous fluid imbalancecontrolmedical practitioner
* We use standard office opening hours in near Reprieve Cardiovascular's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Reprieve Cardiovascular is Diagnostic Equipment business from United States that founded in 2018 (6 years old in 2024), Reprieve Cardiovascular business is focusing on Medical Device.
Reprieve Cardiovascular headquarter office and corporate office address is located in 459 Fortune Boulevard Milford, MA 01757 United States.
Reprieve Cardiovascular was founded in United States.
In 2024, Reprieve Cardiovascular is currently focus on medical device sector.
Above is snippet of Google Trends for "medical device" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Reprieve Cardiovascular, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
